findmyKOL

Victoria Werth, MD

Enriched profile

Professor of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania; Chief, Division of Dermatology, Philadelphia VA Medical Center · Perelman School of Medicine at the University of Pennsylvania

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Philadelphia, PA · Northeast · United StatesSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2001–2026

Victoria Werth is Professor of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania; Chief, Division of Dermatology, Philadelphia VA Medical Center at Perelman School of Medicine at the University of Pennsylvania. OpenAlex indexes 792 publications with 31,737 citations (h-index 83); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Dermatology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 18 Oct 2026

Victoria P. Werth, MD, is Professor of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania at Perelman School of Medicine at the University of Pennsylvania. The public record shows 792 publications with 31,737 citations (h-index 83), centered on Dermatology. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 35 companies, 7 NIH-funded awards (2001–2026).

  • Most recent indexed publication: 2026 · Lupus science & medicine
  • Top research focus: Dermatology
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 35 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Pemphigus4 trialsLupus (SLE)4 trialsErythema4 trialsLupus Erythematosus, Cutaneous4 trialsMyositis3 trialsDermatomyositis3 trialsPemphigoid, Bullous1 trial

Research focus

OpenAlex concept fingerprint
Dermatology

Drugs & molecules

across trials, industry payments and publications
Dupixentgeneric · DupilumabClinical trials—Industry payments66Publications—Fasenrageneric · BenralizumabClinical trials—Industry payments14Publications—Saphnelogeneric · AnifrolumabClinical trials—Industry payments13Publications—Benlystageneric · BelimumabClinical trials—Industry payments9Publications—Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments7Publications—OCTAGAM IMMUNE GLOBULINClinical trials—Industry payments6Publications—Panzygageneric · Immunoglobulin GClinical trials—Industry payments4Publications—Cosentyxgeneric · SecukinumabClinical trials—Industry payments2Publications—Briumvigeneric · UblituximabClinical trials—Industry payments1Publications—Cibinqogeneric · AbrocitinibClinical trials—Industry payments1Publications—Epkinlygeneric · EpcoritamabClinical trials—Industry payments1Publications—Litfulogeneric · RitlecitinibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments45Genzyme CorporationClinical trials—Industry payments37Merck Sharp & Dohme LLCClinical trials—Industry payments34E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments28AstraZeneca UK LimitedClinical trials—Industry payments26Biogen, Inc.Clinical trials—Industry payments19Pfizer Inc.Clinical trials—Industry payments17GlaxoSmithKline, LLC.Clinical trials—Industry payments13Janssen Research & Development, LLCClinical trials—Industry payments12Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments11AstraZeneca Pharmaceuticals LPClinical trials—Industry payments10Argenx Us, Inc.Clinical trials—Industry payments9Sanofi-Aventis U.S. LLCClinical trials—Industry payments9Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments8Eli Lilly and CompanyClinical trials—Industry payments6EMD Serono, Inc.Clinical trials—Industry payments6Merck KGaAClinical trials—Industry payments6Novartis Pharmaceuticals CorporationClinical trials—Industry payments6Octapharma USA, Inc.Clinical trials—Industry payments6EMD Serono Research & Development Institute, Inc.Clinical trials—Industry payments5Kyowa Kirin Co., LtdClinical trials—Industry payments5Ucb SaClinical trials—Industry payments5University of PennsylvaniaClinical trials5Industry payments—Gilead Sciences, Inc.Clinical trials—Industry payments3Principia Biopharma Inc.Clinical trials—Industry payments3Almirall LLCClinical trials—Industry payments2Corbus Pharmaceuticals Inc.Clinical trials2Industry payments—CSL BehringClinical trials—Industry payments2Merck Healthcare KGaAClinical trials—Industry payments2Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
792publications

Distinct works indexed by OpenAlex, matched via ORCID; 61 in PubMed.

31,737citations

Total citations across indexed works.

83h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials ↓
35companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
7NIH grants · 2001–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

35 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Antiparasitic

    20.2%
    Antimalarial20.2%
    Hydroxychloroquine Sulfate92%Chloroquine Phosphate8%
    Part D<11 patients
  • Cancer & immunology

    17.1%
    Folate Analog Metabolic Inhibitor12.9%
    Methotrexate100%
    Part D≥26 patients
    Calcineurin inhibitor3%
    Tacrolimus100%
    Part D≥12 patients

    + 1 more class in this area

  • Dermatology

    16.1%
    Corticosteroid8.4%
    Triamcinolone Acetonide100%
    Part D≥54 patients
    Interleukin-4 Receptor alpha Antagonist6.6%
    Dupixent Pen80%Dupixent Syringe20%
    Part D<11 patients

    + 1 more class in this area

All 7 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

7 NIH research awards on record, funded 2001–2026 per NIH RePORTER. The latest:

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/victoria-werth-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Victoria-P-Werth-38760885

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/lupusresearchalliance/posts/-meet-dr-victoria-werth-a-dedicated-researcher-whos-on-a-mission-to-find-better-/888741206626361

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Internal Medicine

    1983
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
  • M.D.

    Johns Hopkins University School of Medicine

    1980
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
  • B.A. Chemistry

    Catholic University of America

    1976
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
  • M.S. Physical Chemistry

    Catholic University of America

    1976
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
  • Board Certified

    Dermatology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗

Editorial & leadership roles

journal and society appointments
  • Co-founder and past president

    Rheumatologic Dermatology Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
  • Co-founder

    Medical Dermatology Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
  • Editorial Advisory Board

    British Journal of Dermatology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Guest

    Derm Club Podcast (Dr. Hannah Kopelman), discussion of lupus treatment and pathophysiology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hannahkopelman.com ↗
  • Interview guest

    AAD Dialogues in Dermatology podcast, dermatomyositis subtypes and clinical progression

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →resources.aad.org ↗
  • Featured expert

    "TMA Ask The Doc: Dermatology" webinar, The Myositis Association

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myositis.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.